O'Neil Global Advisors, Inc. Lantheus Holdings, Inc. Transaction History

O'Neil Global Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$47.76 - $82.86 $382,939 - $664,371	8,018 New	8,018 $662,000
Q3 2022 Nov 15, 2022	SELL	$61.42 - $86.29 $455,490 - $639,926	-7,416 Closed	0 $0
Q2 2022 Sep 12, 2022	BUY	$55.54 - $72.65 $100,360 - $131,278	1,807 Added 32.22%	7,416 $490,000
Q1 2022 May 12, 2022	BUY	$24.28 - $56.64 $136,186 - $317,693	5,609 New	5,609 $310,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.